Terms: = Skin cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
8 results:
1. Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy.
Dimitriou F; Hogan S; Menzies AM; Dummer R; Long GV
Eur J Cancer; 2021 Nov; 157():214-224. PubMed ID: 34536945
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study.
Song H; Zhong CS; Kieran MW; Chi SN; Wright KD; Huang JT
Pediatr Blood Cancer; 2019 Jun; 66(6):e27682. PubMed ID: 30821092
[TBL] [Abstract] [Full Text] [Related]
3. Sirolimus in blue rubber bleb naevus syndrome: A systematic review.
Wong XL; Phan K; Rodríguez Bandera AI; Sebaratnam DF
J Paediatr Child Health; 2019 Feb; 55(2):152-155. PubMed ID: 30565378
[TBL] [Abstract] [Full Text] [Related]
4. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
[TBL] [Abstract] [Full Text] [Related]
5. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
[TBL] [Abstract] [Full Text] [Related]
6. Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells.
Mergler S; Derckx R; Reinach PS; Garreis F; Böhm A; Schmelzer L; Skosyrski S; Ramesh N; Abdelmessih S; Polat OK; Khajavi N; Riechardt AI
Cell Signal; 2014 Jan; 26(1):56-69. PubMed ID: 24084605
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
Casanova ML; Blázquez C; Martínez-Palacio J; Villanueva C; Fernández-Aceñero MJ; Huffman JW; Jorcano JL; Guzmán M
J Clin Invest; 2003 Jan; 111(1):43-50. PubMed ID: 12511587
[TBL] [Abstract] [Full Text] [Related]
8. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand].
Gatzemeier W; Orecchia R; Gatti G; Intra M; Veronesi U
Strahlenther Onkol; 2001 Jul; 177(7):330-7. PubMed ID: 11505618
[TBL] [Abstract] [Full Text] [Related]
